George Quartey

发表

A semi-parametric approach to analysis of event duration and prevalence

Jixian Wang, George Quartey, 2013, Comput. Stat. Data Anal..

Device for attracting moth

George Quartey, Thomas Henry Coaker, Owen T Jones, 1991 .

Overview of Benefit–Risk Evaluation Methods: A Spectrum from Qualitative to Quantitative

Guochen Song, George Quartey, Christy Chuang-Stein, 2017 .

Considerations on Endpoint Selection, Weighting Determination, and Uncertainty Evaluation in the Benefit-Risk Assessment of Medical Product

Christy Chuang-Stein, John Scott, Scott R. Evans, 2016 .

Nonparametric estimation for cumulative duration of adverse events.

Jixian Wang, George Quartey, 2012, Biometrical journal. Biometrische Zeitschrift.

Practical Analysis and Visualization Tools for Benefit-Risk Assessment in Drug Development: A Review of Recent FDA Advisory Committee Meeting Packages

Christy Chuang-Stein, Mondira Bhattacharya, Scott R. Evans, 2016 .

Responses to discussants of ‘Joint modeling of survival and longitudinal non‐survival data: current methods and issues. report of the DIA Bayesian joint modeling working group’

Joseph G. Ibrahim, A. Lawrence Gould, George Quartey, 2015, Statistics in medicine.

Guidance on the implementation and reporting of a drug safety Bayesian network meta‐analysis

Bradley P Carlin, Haoda Fu, Jouni Kerman, 2014, Pharmaceutical statistics.

Joint modeling of survival and longitudinal non‐survival data: current methods and issues. Report of the DIA Bayesian joint modeling working group

Joseph G Ibrahim, Michael J Crowther, George Quartey, 2015, Statistics in medicine.

In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI

Martin J Graves, Elizabeth Warburton, George Quartey, 2004, Stroke.

Why a Bayesian approach to safety analysis in pharmacovigilance is important

George Quartey, David Prieto-Merino, Jixian Wang, 2011, Pharmaceutical statistics.

Selecting and Integrating Data Sources in Benefit–Risk Assessment: Considerations and Future Directions

Christy Chuang-Stein, Jesse A. Berlin, George Quartey, 2016 .

Understanding and Evaluating Uncertainties in the Assessment of Benefit–Risk in Pharmaceutical Drug Development

Qi Jiang, Christy Chuang-Stein, Scott R. Evans, 2017 .